What we did here is look at tissue in 3D and then map the genetic alterations onto that 3D model,” explained Laura Wood, M.D., Ph.D., Associate Professor of Pathology and Oncology at the Johns Hopkins ...
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback